CAS 4444-42-2
:Desmetilnortriptilina
- 1-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-
- 3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-propanamine
- 5H-Dibenzo[a,d]cycloheptene-Δ<sup>5,γ</sup>-propylamine, 10,11-dihydro-
- Demethylnortriptyline
- Desmethylnortriptyline
- Didesmethylamitriptyline
- Lu 5-079
- N,N-Didemethylamitriptyline
- 5H-Dibenzo[a,d]cycloheptene-Δ5,γ-propylamine, 10,11-dihydro-
- 3-(10,11-Dihydro-5H-dibenzo[a,d]cycloheptene-5-ylidene)-1-propaneamine
- Nortriptyline Impurity 19
- 3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propan-1-amine(WXG02098)
- Vedi altri sinonimi
Ref: 4Z-N-3620
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaDesmethylnortriptyline
CAS:Desmethylnortriptyline, a tricyclic antidepressant metabolite of nortriptyline and amitriptyline, treats depression.Formula:C18H19NPurezza:98%Colore e forma:SolidPeso molecolare:249.35Desmethylnortriptyline
CAS:Prodotto controllatoApplications Desmethylnortriptyline is a metabolite of Nortriptyline which is used in the treatment of depression and migraines.
References Cheng, F., et al.: J. Brazil Chem. Soc., 19, 35 (2008)Formula:C18H19NColore e forma:NeatPeso molecolare:249.35Desmethylnortriptyline
CAS:Desmethylnortriptyline is a tricyclic antidepressant drug that has been shown to have anti-inflammatory properties. It inhibits the production of inflammatory cytokines in the intestine, which may be due to its effect on the induction of apoptosis by inhibiting protein synthesis. Desmethylnortriptyline also has a beneficial effect on bowel diseases, such as colitis and ileitis. This drug inhibits the uptake of serotonin in rat brains and can lead to decreased levels of serotonin in the brain and spinal cord, which may be responsible for its clinical response. Desmethylnortriptyline is metabolized by demethylation and deamination. It undergoes oxidative deamination by cytochrome P450 enzymes found in human liver microsomes and isolated heart tissue, generating an inactive product. The drug also undergoes oxidation by uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) to form an active metabolite.
Formula:C18H19NPurezza:Min. 95%Peso molecolare:249.3 g/molRef: ST-EA-CP-N15017
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta




